Kewaunee Scientific Co. (NASDAQ:KEQU) CFO Sells $113,250.00 in Stock

Kewaunee Scientific Co. (NASDAQ:KEQU) CFO Donald T. Gardner III sold 3,000 shares of the business’s stock in a transaction on Wednesday, April 9th. The shares were sold at an average price of $37.75, for a total transaction of $113,250.00. Following the completion of the transaction, the chief financial officer now directly owns 15,358 shares of the company’s stock, valued at $579,764.50. This trade represents a 16.34 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Kewaunee Scientific Stock Down 4.6 %

KEQU stock traded down $1.61 during mid-day trading on Friday, hitting $32.95. 2,326 shares of the company were exchanged, compared to its average volume of 23,494. The company has a debt-to-equity ratio of 0.45, a quick ratio of 2.13 and a current ratio of 2.64. Kewaunee Scientific Co. has a 1-year low of $30.82 and a 1-year high of $71.33. The firm’s 50 day simple moving average is $50.30 and its 200 day simple moving average is $47.36. The firm has a market cap of $94.06 million, a P/E ratio of 5.22 and a beta of 0.59.

Kewaunee Scientific (NASDAQ:KEQU) last issued its quarterly earnings data on Wednesday, March 12th. The technology company reported $1.09 EPS for the quarter. The business had revenue of $67.17 million for the quarter. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%.

Analyst Ratings Changes

Separately, StockNews.com cut Kewaunee Scientific from a “buy” rating to a “hold” rating in a research note on Friday, March 14th.

Institutional Trading of Kewaunee Scientific

Several hedge funds and other institutional investors have recently modified their holdings of KEQU. State Street Corp bought a new position in shares of Kewaunee Scientific during the third quarter worth about $266,000. Barclays PLC acquired a new position in Kewaunee Scientific during the 3rd quarter worth approximately $121,000. Geode Capital Management LLC boosted its position in Kewaunee Scientific by 8.9% during the 3rd quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company’s stock worth $792,000 after acquiring an additional 1,941 shares during the last quarter. JPMorgan Chase & Co. grew its stake in shares of Kewaunee Scientific by 18,000.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company’s stock worth $30,000 after acquiring an additional 900 shares in the last quarter. Finally, Ritholtz Wealth Management raised its holdings in shares of Kewaunee Scientific by 15.6% in the fourth quarter. Ritholtz Wealth Management now owns 12,619 shares of the technology company’s stock valued at $781,000 after purchasing an additional 1,706 shares during the last quarter. Institutional investors and hedge funds own 32.69% of the company’s stock.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.